Clearside Biomedical, Inc.
CLSD
|
News
P
|
$1.4
-0.71%
150K
|
Health Technology
(0.0% 1d) (-18.5% 1m) (28.2% 1y) (0.0% 2d) (0.0% 3d) (7.6% 7d) (31.06% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 104,609,595
http://www.clearsidebio.com
Sec Filling | Patents | 33 employees
(US) Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
eye gene therapies
add to watch list Paper trade email alert is off
Press-releases
Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
macular growth market
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
ALPMF | News | $9.75 200
|
Health Technology
|
| O: -3.69%
H: 5.08%
C: 5.08%
ALPMY | News | $9.53 690K
|
Manufacturing
|
| O: -1.31%
H: 2.95%
C: 2.08%
IFRX | $1.385 1.1% 61K
|
Health Technology
|
| O: -4.17%
H: 2.17%
C: -5.07%
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 1.61%
H: 0.79%
C: -8.73%
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 4.61%
H: 2.44%
C: -11.95%
conference
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
Published: 2024-03-28 (Crawled : 11:00) - prnewswire.com
RGNX | $15.94 1.92% 88K
|
Health Technology
|
| O: 0.68%
H: 0.4%
C: -5.64%
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: -0.6%
H: 4.22%
C: -7.83%
rgx-314 lancet publication therapy study
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Published: 2024-03-18 (Crawled : 11:00) - globenewswire.com
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 4.09%
H: 0.0%
C: -12.36%
medical
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 6.1%
H: 10.06%
C: -6.32%
year update financial results
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
Published: 2024-02-29 (Crawled : 12:00) - globenewswire.com
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: -2.1%
report year update financial results
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: -4.26%
H: 4.44%
C: 2.22%
million direct offering
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
Published: 2024-01-16 (Crawled : 20:00) - prnewswire.com
SRPT | $119.28 1.98% 88K
|
Health Technology
|
| O: -0.49%
H: 3.17%
C: 1.94%
RGNX | $15.94 1.92% 88K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -7.15%
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.94%
rgx-314 aaviate positive treatment trial
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
Published: 2023-12-14 (Crawled : 12:00) - globenewswire.com
CLSD | News P | $1.4 -0.71% 150K
|
Health Technology
|
| O: 1.92%
H: 2.83%
C: -1.89%
cls-ax trial
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.75 79.52% 1.5M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
LOCL | $3.33 27.59% 43K
|
Last 48 Hours Insiders Buying
HNVR | $16.35 800
|
|
16:30
VUZI P 34500 | $1.375 1.85% 280K
|
Electronic Technology
|
16:00
TPL P 3 | $584.65 -0.2% 7.4K
|
Miscellaneous
|
15:00
ETST P 79000 | $0.065 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $21.57 0.33% 46K
|
Consumer Durables
|
00:00
YORW P 29 | $35.655 0.66% 18K
|
Utilities
|
19:01
BANF P 256 | $92.28 1.1% 17K
|
Finance
|
15:30
RMCF | $3.57 170
|
Consumer Non-Durables
|
20:10